Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Activation of FXR pathway does not alter glial cell function.

Albrecht S, Fleck AK, Kirchberg I, Hucke S, Liebmann M, Klotz L, Kuhlmann T.

J Neuroinflammation. 2017 Mar 28;14(1):66. doi: 10.1186/s12974-017-0833-6.

2.

Transplanted miR-219-overexpressing oligodendrocyte precursor cells promoted remyelination and improved functional recovery in a chronic demyelinated model.

Fan HB, Chen LX, Qu XB, Ren CL, Wu XX, Dong FX, Zhang BL, Gao DS, Yao RQ.

Sci Rep. 2017 Feb 1;7:41407. doi: 10.1038/srep41407.

3.

FSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanisms.

Li YH, Xie C, Zhang Y, Li X, Zhang HF, Wang Q, Chai Z, Xiao BG, Thome R, Zhang GX, Ma CG.

Sci Rep. 2017 Jan 23;7:41227. doi: 10.1038/srep41227.

4.
5.

Taking Advantage of Nature's Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration?

Akkermann R, Jadasz JJ, Azim K, Küry P.

Int J Mol Sci. 2016 Nov 14;17(11). pii: E1895. Review.

6.

Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes.

Poutiainen P, Jaronen M, Quintana FJ, Brownell AL.

Front Mol Neurosci. 2016 Sep 15;9:85. eCollection 2016. Review.

7.

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery.

Mei F, Lehmann-Horn K, Shen YA, Rankin KA, Stebbins KJ, Lorrain DS, Pekarek K, A Sagan S, Xiao L, Teuscher C, von Büdingen HC, Wess J, Lawrence JJ, Green AJ, Fancy SP, Zamvil SS, Chan JR.

Elife. 2016 Sep 27;5. pii: e18246. doi: 10.7554/eLife.18246.

8.

Protandim Protects Oligodendrocytes against an Oxidative Insult.

Lim JL, van der Pol SM, Baron W, McCord JM, de Vries HE, van Horssen J.

Antioxidants (Basel). 2016 Sep 7;5(3). pii: E30. doi: 10.3390/antiox5030030.

9.

ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.

Jeffries MA, Urbanek K, Torres L, Wendell SG, Rubio ME, Fyffe-Maricich SL.

J Neurosci. 2016 Aug 31;36(35):9186-200. doi: 10.1523/JNEUROSCI.1444-16.2016.

10.

Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.

Redmond SA, Mei F, Eshed-Eisenbach Y, Osso LA, Leshkowitz D, Shen YA, Kay JN, Aurrand-Lions M, Lyons DA, Peles E, Chan JR.

Neuron. 2016 Aug 17;91(4):824-36. doi: 10.1016/j.neuron.2016.07.021. Epub 2016 Aug 4.

PMID:
27499083
11.

Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning.

Xiao L, Ohayon D, McKenzie IA, Sinclair-Wilson A, Wright JL, Fudge AD, Emery B, Li H, Richardson WD.

Nat Neurosci. 2016 Sep;19(9):1210-7. doi: 10.1038/nn.4351. Epub 2016 Jul 25.

12.

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.

Absinta M, Sati P, Schindler M, Leibovitch EC, Ohayon J, Wu T, Meani A, Filippi M, Jacobson S, Cortese IC, Reich DS.

J Clin Invest. 2016 Jul 1;126(7):2597-609. doi: 10.1172/JCI86198. Epub 2016 Jun 6.

13.

Regenerative Capacity of Macrophages for Remyelination.

Rawji KS, Mishra MK, Yong VW.

Front Cell Dev Biol. 2016 May 20;4:47. doi: 10.3389/fcell.2016.00047. eCollection 2016. Review.

14.

Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis.

Yandamuri SS, Lane TE.

Front Immunol. 2016 May 19;7:189. doi: 10.3389/fimmu.2016.00189. eCollection 2016. Review.

15.

A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms.

Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S, Suarez J, Michalsen A, Cross AH, Morgan TE, Wei M, Paul F, Bock M, Longo VD.

Cell Rep. 2016 Jun 7;15(10):2136-46. doi: 10.1016/j.celrep.2016.05.009. Epub 2016 May 26.

16.

The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination.

Laitman BM, Asp L, Mariani JN, Zhang J, Liu J, Sawai S, Chapouly C, Horng S, Kramer EG, Mitiku N, Loo H, Burlant N, Pedre X, Hara Y, Nudelman G, Zaslavsky E, Lee YM, Braun DA, Lu QR, Narla G, Raine CS, Friedman SL, Casaccia P, John GR.

PLoS Biol. 2016 May 23;14(5):e1002467. doi: 10.1371/journal.pbio.1002467. eCollection 2016 May.

17.

Advanced MRI and staging of multiple sclerosis lesions.

Absinta M, Sati P, Reich DS.

Nat Rev Neurol. 2016 Jun;12(6):358-68. doi: 10.1038/nrneurol.2016.59. Epub 2016 Apr 29. Review.

PMID:
27125632
18.

The role of growth factors as a therapeutic approach to demyelinating disease.

Huang Y, Dreyfus CF.

Exp Neurol. 2016 Sep;283(Pt B):531-40. doi: 10.1016/j.expneurol.2016.02.023. Epub 2016 Mar 22. Review.

PMID:
27016070
19.

Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

Gaesser JM, Fyffe-Maricich SL.

Exp Neurol. 2016 Sep;283(Pt B):501-11. doi: 10.1016/j.expneurol.2016.03.008. Epub 2016 Mar 5. Review.

PMID:
26957369
20.

Dynamic imaging of individual remyelination profiles in multiple sclerosis.

Bodini B, Veronese M, García-Lorenzo D, Battaglini M, Poirion E, Chardain A, Freeman L, Louapre C, Tchikviladze M, Papeix C, Dollé F, Zalc B, Lubetzki C, Bottlaender M, Turkheimer F, Stankoff B.

Ann Neurol. 2016 Feb 18. doi: 10.1002/ana.24620. [Epub ahead of print]

Supplemental Content

Support Center